NCT00368277View on ClinicalTrials.gov

A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly

PHASE3CompletedINTERVENTIONAL
Enrollment

901

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Hypertension
Interventions
DRUG

Aliskiren

Aliskiren 150 mg and 300 mg tablets taken orally, once a day in the morning

DRUG

Ramipril

Ramipril 5 mg and 10 mg capsules taken orally, once a day in the morning

DRUG

Hydrochlorothiazide

Hydrochlorothiazide 12.5 or 25 mg capsules taken orally, once a day in the morning

DRUG

Amlodipine

Amlodipine 5 mg or 10 mg tablets taken orally, once a day in the morning

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY